Furthermore, interleukin (IL)-17, IFN-γ, and tumor necrosis factor alpha (TNF-α) can independently control PD-L1 by activating AKT, nuclear factor-κB (NFκB), and extracellular regulated protein kinase (ERK) signaling in cancer cells [13]. The gene discussed is CD274; the disease is cancer.